Elevance Health closes BioPlus acquisition

Rylee Wilson -  

Elevance Health has closed its acquisition of specialty pharmacy BioPlus. 

The company plans to expand BioPlus' service models to more complex disease treatment, Elevance Health said in a Feb. 15 news release. 

BioPlus, a division of pharmaceutical company CarepathRx, provides specialty pharmacy management for complex conditions such as cancer, multiple sclerosis and autoimmune diseases. 

Elevance Health said it would acquire BioPlus Nov. 9. The specialty pharmacy will operate as part of its pharmaceutical benefit manager, CarelonRx. 

Subscribe to the following topics: elevance healthbiopluscarelonrxcarepathrxspecialty pharmacy

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers

Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.

 

Already Registered? Click here to confirm.